1
|
Martin-Quesada AI, Llabres-Valentí E, Montesdeoca-Godoy CM, Martín-Abreu C, Alemán-Sánchez C, Rodríguez-Pérez N, Herrero-Márquez A, Cruz-Jurado J, Hernández-Sosa M, Marrero-García M, DelPino-Hernández CV, Hernández-Sarmiento SJ, Rodríguez-Capote A, Pérez-Méndez L, Núñez-Hernández I. Comparative study of weekly and three-weekly neoadjuvant carboplatin in triple-negative breast cancer: retrospective analysis in real-world settings. Clin Transl Oncol 2024:10.1007/s12094-024-03430-7. [PMID: 38509430 DOI: 10.1007/s12094-024-03430-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2023] [Accepted: 02/27/2024] [Indexed: 03/22/2024]
Abstract
PURPOSE Tri-weekly carboplatin is an established neoadjuvant treatment for triple-negative breast cancer, enhancing pathological complete response (pCR) and overall survival. This study explores if weekly carboplatin provides lower toxicity and comparable pCR rates. METHODS/PATIENTS A retrospective multicenter study (January 2021 to March 2023) compares outcomes of weekly and tri-weekly carboplatin. RESULTS Among 104 participants, 60% received weekly and 40% tri-weekly treatments. Weekly administration had fewer discontinuations (56.5 vs. 70.7%, p = 0.154). Both schedules exhibited similar overall toxicity (p = 0.087), with slightly higher grade 3-4 toxicity in the tri-weekly group (56.1 vs. 48.4%, p = 0.126). Hematological toxicity was comparable, but the weekly group experienced more diarrhea (p = 0.432) and asthenia (p = 0.012). Weekly treatment correlated with more frequent breast-conserving surgeries (p = 0.004). pCR rates were 50% with weekly and 61% with tri-weekly regimens (p = 0.186). CONCLUSIONS Weekly carboplatin exhibited comparable toxicity, a trend toward fewer interruptions, and similar pCR rates. Prospective studies are essential for validating these findings.
Collapse
Affiliation(s)
- Ana Isabel Martin-Quesada
- Medical Oncologist, University Hospital Nuestra Señora de Candelaria, Ctra. Gral. del Rosario, 145, 38010, Santa Cruz de Tenerife, Spain.
- Immuno Oncology Unit, Centre Hospitalier Universitaire, Rue de Bugnon 46, 1005, Lausanne, Switzerland.
| | - Elisenda Llabres-Valentí
- Medical Oncologist, Insular Materno-Infantil University Hospital, Avenida Marítima del Sur, S/N, 35016, Las Palmas de Gran Canaria, Las Palmas, Spain
| | - Cristina María Montesdeoca-Godoy
- Medical Oncologist, Insular Materno-Infantil University Hospital, Avenida Marítima del Sur, S/N, 35016, Las Palmas de Gran Canaria, Las Palmas, Spain
| | - Carla Martín-Abreu
- Medical Oncologist, University Hospital of the Canary Islands, Carretera Ofra S/N, 38320, La Laguna, Santa Cruz de Tenerife, Spain
| | - Cristina Alemán-Sánchez
- Medical Oncologist, University Hospital of the Canary Islands, Carretera Ofra S/N, 38320, La Laguna, Santa Cruz de Tenerife, Spain
| | - Natalia Rodríguez-Pérez
- Medical Oncologist, University Hospital Nuestra Señora de Candelaria, Ctra. Gral. del Rosario, 145, 38010, Santa Cruz de Tenerife, Spain
| | - Alicia Herrero-Márquez
- Medical Oncologist, University Hospital Nuestra Señora de Candelaria, Ctra. Gral. del Rosario, 145, 38010, Santa Cruz de Tenerife, Spain
| | - Josefina Cruz-Jurado
- Medical Oncologist, University Hospital of the Canary Islands, Carretera Ofra S/N, 38320, La Laguna, Santa Cruz de Tenerife, Spain
| | - María Hernández-Sosa
- Medical Oncologist, Doctor Negrín University Hospital, C. Pl. Barranco de La Ballena, S/N, 35010, Las Palmas de Gran Canaria, Las Palmas, Spain
| | - Melody Marrero-García
- Medical Oncologist, Doctor Negrín University Hospital, C. Pl. Barranco de La Ballena, S/N, 35010, Las Palmas de Gran Canaria, Las Palmas, Spain
| | | | - Samuel José Hernández-Sarmiento
- Medical Oncologist, Virgen de La Peña General Hospital, Carretera del Aeropuerto, Km 1, 35600, Puerto del Rosario, Las Palmas, Spain
| | - Alejandra Rodríguez-Capote
- Medical Oncologist, University Hospital de La Palma, LP-3, 28, 38713, Breña Alta, Santa Cruz de Tenerife, Spain
| | - Lina Pérez-Méndez
- Department of Clinical Epidemiology and Biostatistics, Research Unit, University Hospital Nuestra Señora de Candelaria Tenerife and Primary Care Management, Santa Cruz de Tenerife, Spain
- Networked Biomedical Research Centre (CIBER) of Respiratory Diseases, Ctra. Gral. del Rosario, Carlos III Health Institute, 145, 38010, Santa Cruz de Tenerife, Spain
| | - Isaac Núñez-Hernández
- Medical Oncologist, University Hospital Nuestra Señora de Candelaria, Ctra. Gral. del Rosario, 145, 38010, Santa Cruz de Tenerife, Spain
| |
Collapse
|